Company overview
DeNovix designs, manufactures, and sells spectrophotometers, fluorometers, and assay kits for quantifying DNA, RNA, and proteins in life science labs. Their DS-11 Series and DS-Series instruments offer UV-Vis and fluorescence detection with wide dynamic ranges, enabling accurate measurements from as low as 0.5 pg/µL dsDNA. Assay kits provide superior selectivity in the presence of contaminants compared to competitors.
Laboratory Equipment is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include denovix, spectrophotometer, fluorometer, dsdna assay, rna quantification.
Products and technologies associated with Laboratory Equipment include Assay — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.denovix.com
- Markets served
- United States & Americas
- Keywords
- denovix, spectrophotometer, fluorometer, dsdna assay, rna quantification
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What instruments does DeNovix offer for nucleic acid quantification?
- DeNovix offers the DS-11 Series and DS-Series spectrophotometers and fluorometers for UV-Vis and fluorescence quantification of DNA, RNA, and proteins using 1 µL samples.
- What are the detection ranges of DeNovix dsDNA assays?
- DeNovix dsDNA assays cover Broad Range (0.1–2000 ng/µL), High Sensitivity (10 pg/µL–250 ng/µL), and Ultra High Sensitivity (0.5–300 pg/µL), with extended ranges available.
- Where is DeNovix based and what is their focus?
- DeNovix is a Delaware, USA-based company founded in 2012, specializing in innovative life science instrumentation with emphasis on optics, detection, and customer support.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
